The PPARGC1A Gly482Ser polymorphism is associated with left ventricular diastolic dysfunction in men

BMC Cardiovascular Disorders

Volumn 8, Issue , 2008, Pages

  Ingelsson, Erik ^a   Bennet, Louise ^b   Ridderstråle, Martin ^b   Söderström, Marianne ^c   Råstam, Lennart ^b   Lindblad, Ulf ^d,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c SKARABORG HOSPITAL   (Sweden)

^d Skaraborgs Institutet   (Sweden)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLYCINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SERINE; HEAT SHOCK PROTEIN; PPARGC1A PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; AGE; AGED; ALLELE; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DIASTOLIC DYSFUNCTION; DNA EXTRACTION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HEART LEFT VENTRICLE FILLING; HUMAN; HYPERTENSION; LEISURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK REDUCTION; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE; WAIST HIP RATIO; COHORT ANALYSIS; COMPARATIVE STUDY; GENETICS; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; SEXUAL DEVELOPMENT;

ADULT; AGED; ALLELES; COHORT STUDIES; FEMALE; GLYCINE; HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SERINE; SEX CHARACTERISTICS; TRANSCRIPTION FACTORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 60849124818     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-8-37     Document Type: Article

References (50)

1. Lloyd-Jones DM Larson MG Leip EP Beiser A D'Agostino RB Kannel WB Murabito JM Vasan RS Benjamin EJ Levy D Lifetime risk for developing congestive heart failure: The Framingham Heart Study Circulation 2002, 106(24):3068-3072. 10.1161/01.CIR.0000039105.49749.6F 12473553
2. Vasan RS Larson MG Benjamin EJ Evans JC Reiss CK Levy D Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: Prevalence and mortality in a population-based cohort J Am Coll Cardiol 1999, 33(7):1948-1955. 10.1016/S0735-1097(99)00118-7 10362198
3. Devereux RB Roman MJ Liu JE Welty TK Lee ET Rodeheffer R Fabsitz RR Howard BV Congestive heart failure despite normal left ventricular systolic function in a population-based sample: The Strong Heart Study Am J Cardiol 2000, 86(10):1090-1096. 10.1016/S0002-9149(00)01165-6 11074205
4. Hogg K Swedberg K McMurray J Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis J Am Coll Cardiol 2004, 43(3):317-327. 10.1016/ j.jacc.2003.07.046 15013109
5. Aurigemma GP Gottdiener JS Shemanski L Gardin J Kitzman D Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: The cardiovascular health study J Am Coll Cardiol 2001, 37(4):1042-1048. 10.1016/S0735-1097(01)01110-X 11263606
6. Bella JN Palmieri V Roman MJ Liu JE Welty TK Lee ET Fabsitz RR Howard BV Devereux RB Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study Circulation 2002, 105(16):1928-1933. 10.1161/ 01.CIR.0000015076.37047.D9 11997279
7. Poulsen SH Jensen SE Nielsen JC Moller JE Egstrup K Serial changes and prognostic implications of a Doppler-derived index of combined left ventricular systolic and diastolic myocardial performance in acute myocardial infarction Am J Cardiol 2000, 85(1):19-25. 10.1016/ S0002-9149(99)00599-8 11078230
8. Kenchaiah S Evans JC Levy D Wilson PW Benjamin EJ Larson MG Kannel WB Vasan RS Obesity and the risk of heart failure N Engl J Med 2002, 347(5):305-313. 10.1056/NEJMoa020245 12151467
9. Fischer M Baessler A Hense HW Hengstenberg C Muscholl M Holmer S Doring A Broeckel U Riegger G Schunkert H Prevalence of left ventricular diastolic dysfunction in the community. Results from a Doppler echocardiographic-based survey of a population sample Eur Heart J 2003, 24(4):320-328. 10.1016/S0195-668X(02)00428-1 12581679
10. Puigserver P Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha Int J Obes (Lond) 2005, 29(Suppl 1):S5-9. 10.1038/sj.ijo.0802905 15711583
11. Ek J Andersen G Urhammer SA Gaede PH Drivsholm T Borch-Johnsen K Hansen T Pedersen O Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus Diabetologia 2001, 44(12):2220-2226. 10.1007/s001250100032 11793024
12. Andrulionyte L Zacharova J Chiasson JL Laakso M Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial Diabetologia 2004, 47(12):2176-2184. 10.1007/s00125-004-1577-2 15592662
13. Hara K Tobe K Okada T Kadowaki H Akanuma Y Ito C Kimura S Kadowaki T A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes Diabetologia 2002, 45(5):740-743. 10.1007/s00125-002-0803-z 12107756
14. Barroso I Luan J Sandhu MS Franks PW Crowley V Schafer AJ O'Rahilly S Wareham NJ Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes Diabetologia 2006, 49(3):501-505. 10.1007/s00125-005-0130-2 16435105
15. Andersen G Wegner L Jensen DP Glumer C Tarnow L Drivsholm T Poulsen P Hansen SK Nielsen EM Ek J et al PGC-1alpha Gly482Ser polymorphism associates with hypertension among Danish whites Hypertension 2005, 45(4):565-570. 10.1161/01.HYP.0000158946.53289.24 15738346
16. Oberkofler H Holzl B Esterbauer H Xie M Iglseder B Krempler F Paulweber B Patsch W Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: Associations with hypertension in middle-aged men Hypertension 2003, 41(2):368-372. 10.1161/01.HYP.0000050962.48249.B7 12574109
17. Cheurfa N Reis AF Dubois-Laforgue D Bellanne-Chantelot C Timsit J Velho G The Gly482Ser polymorphism in the peroxisome proliferator-activated receptor-gamma coactivator-1 gene is associated with hypertension in type 2 diabetic men Diabetologia 2004, 47(11):1980-1983. 10.1007/ s00125-004-1567-4 15599700
18. Ridderstrale M Johansson LE Rastam L Lindblad U Increased risk of obesity associated with the variant allele of the PPARGC1A Gly482Ser polymorphism in physically inactive elderly men Diabetologia 2006, 49(3):496-500. 10.1007/s00125-005-0129-8 16474966
19. Esterbauer H Oberkofler H Linnemayr V Iglseder B Hedegger M Wolfsgruber P Paulweber B Fastner G Krempler F Patsch W Peroxisome proliferator-activated receptor-gamma coactivator-1 gene locus: associations with obesity indices in middle-aged women Diabetes 2002, 51(4):1281-1286. 10.2337/diabetes.51.4.1281 11916956
20. Lehman JJ Barger PM Kovacs A Saffitz JE Medeiros DM Kelly DP Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis J Clin Invest 2000, 106(7):847-856. 517815 11018072 10.1172/JCI10268
21. Arany Z He H Lin J Hoyer K Handschin C Toka O Ahmad F Matsui T Chin S Wu PH et al Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle Cell Metab 2005, 1(4):259-271. 10.1016/j.cmet.2005.03.002 16054070
22. Sano M Wang SC Shirai M Scaglia F Xie M Sakai S Tanaka T Kulkarni PA Barger PM Youker KA et al Activation of cardiac Cdk9 represses PGC-1 and confers a predisposition to heart failure EMBO J 2004, 23(17):3559-3569. 516624 15297879 10.1038/sj.emboj.7600351
23. Lindblad U Rastam L Ryden L Ranstam J Berglund G Isacsson SO Reduced stroke incidence with structured hypertension care: The Skaraborg Hypertension Project J Hypertens 1990, 8(12):1147-1153. 10.1097/ 00004872-199012000-00012 1962805
24. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension J Hypertens 2003, 21(6):1011-1053. 10.1097/00004872-200306000-00001 12777938
25. Chobanian AV Bakris GL Black HR Cushman WC Green LA Izzo JL Jr Jones DW Materson BJ Oparil S Wright JT Jr et al The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report Jama 2003, 289(19):2560-2572. 10.1001/jama.289.19.2560 12748199
26. Diabetes Mellitus World Health Organ Tech Rep Ser 1985, 727. 3934850
27. Alberti KG Zimmet PZ Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 1998, 15(7):539-553. 10.1002/ (SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 9686693
28. Alam M Hoglund C Thorstrand C Longitudinal systolic shortening of the left ventricle: An echocardiographic study in subjects with and without preserved global function Clin Physiol 1992, 12(4):443-452. 10.1111/ j.1475-097X.1992.tb00348.x 1505166
29. Jarnert C Mejhert M Ring M Persson H Edner M Doppler tissue imaging in congestive heart failure patients due to diastolic or systolic dysfunction: A comparison with Doppler echocardiography and the atrio-ventricular plane displacement technique Eur J Heart Fail 2000, 2(2):151-160. 10.1016/S1388-9842(00)00075-1 10856728
30. Gudmundsson P Rydberg E Winter R Willenheimer R Visually estimated left ventricular ejection fraction by echocardiography is closely correlated with formal quantitative methods Int J Cardiol 2005, 101(2):209-212. 10.1016/j.ijcard.2004.03.027 15882665
31. Oh JK Appleton CP Hatle LK Nishimura RA Seward JB Tajik AJ The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography J Am Soc Echocardiogr 1997, 10(3):246-270. 10.1016/S0894-7317(97)70062-2 9109691
32. How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure Eur Heart J 1998, 19(7):990-1003. 10.1053/ euhj.1998.1057 9717033
33. Nyholm M Gullberg B Haglund B Rastam L Lindblad U Higher education and more physical activity limit the development of obesity in a Swedish rural population. The Skaraborg Project Int J Obes (Lond) 2008, 32(3):533-540. 10.1038/sj.ijo.0803725 18209739
34. Lai CQ Tucker KL Parnell LD Adiconis X Garcia-Bailo B Griffith J Meydani M Ordovas JM PPARGC1A variation associated with DNA damage, diabetes, and cardiovascular diseases: The Boston Puerto Rican Health Study Diabetes 2008, 57(4):809-816. 10.2337/db07-1238 18162502
35. Wang S Fu C Wang H Shi Y Xu X Chen J Song X Sun K Wang J Fan X et al Polymorphisms of the peroxisome proliferator-activated receptor-gamma coactivator-1alpha gene are associated with hypertrophic cardiomyopathy and not with hypertension hypertrophy Clin Chem Lab Med 2007, 45(8):962-967. 10.1515/CCLM.2007.189 17579564
36. Vimaleswaran KS Radha V Anjana M Deepa R Ghosh S Majumder PP Rao MR Mohan V Effect of polymorphisms in the PPARGC1A gene on body fat in Asian Indians Int J Obes (Lond) 2006, 30(6):884-891. 10.1038/ sj.ijo.0803228 16446747
37. Vohl MC Houde A Lebel S Hould FS Marceau P Effects of the peroxisome proliferator-activated receptor-gamma co-activator-1 Gly482Ser variant on features of the metabolic syndrome Mol Genet Metab 2005, 86(1-2):300-306. 10.1016/j.ymgme.2005.07.002 16122961
38. Ambye L Rasmussen S Fenger M Jorgensen T Borch-Johnsen K Madsbad S Urhammer SA Studies of the Gly482Ser polymorphism of the peroxisome proliferator-activated receptor gamma coactivator 1alpha (PGC-1alpha) gene in Danish subjects with the metabolic syndrome Diabetes Res Clin Pract 2005, 67(2):175-179. 10.1016/j.diabres.2004.06.013 15649578
39. Vimaleswaran KS Luan J Andersen G Muller YL Wheeler E Brito EC O'Rahilly S Pedersen O Baier LJ Knowler WC et al The Gly482Ser genotype at the PPARGC1A gene and elevated blood pressure: A meta-analysis of 13,949 individuals J Appl Physiol 2008 18467552
40. Kannel WB Hjortland M Castelli WP Role of diabetes in congestive heart failure: The Framingham study Am J Cardiol 1974, 34(1):29-34. 10.1016/ 0002-9149(74)90089-7 4835750
41. Ingelsson E Sundstrom J Arnlov J Zethelius B Lind L Insulin resistance and risk of congestive heart failure Jama 2005, 294(3):334-341. 10.1001/ jama.294.3.334 16030278
42. Arnlov J Lind L Sundstrom J Andren B Vessby B Lithell H Insulin resistance, dietary fat intake and blood pressure predict left ventricular diastolic function 20 years later Nutr Metab Cardiovasc Dis 2005, 15(4):242-249. 10.1016/j.numecd.2004.10.002 16054547
43. Ling C Poulsen P Carlsson E Ridderstrale M Almgren P Wojtaszewski J Beck-Nielsen H Groop L Vaag A Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins J Clin Invest 2004, 114(10):1518-1526. 525741 15546003
44. Tcherepanova I Puigserver P Norris JD Spiegelman BM McDonnell DP Modulation of estrogen receptor-alpha transcriptional activity by the coactivator PGC-1 J Biol Chem 2000, 275(21):16302-16308. 10.1074/ jbc.M001364200 10748020
45. Mendelsohn ME Karas RH The protective effects of estrogen on the cardiovascular system N Engl J Med 1999, 340(23):1801-1811. 10.1056/ NEJM199906103402306 10362825
46. Pelzer T Jazbutyte V Hu K Segerer S Nahrendorf M Nordbeck P Bonz AW Muck J Fritzemeier KH Hegele-Hartung C et al The estrogen receptor-alpha agonist 16alpha-LE2 inhibits cardiac hypertrophy and improves hemodynamic function in estrogen-deficient spontaneously hypertensive rats Cardiovasc Res 2005, 67(4):604-612. 10.1016/j.cardiores.2005.04.035 15950203
47. Pelzer T Loza PA Hu K Bayer B Dienesch C Calvillo L Couse JF Korach KS Neyses L Ertl G Increased mortality and aggravation of heart failure in estrogen receptor-beta knockout mice after myocardial infarction Circulation 2005, 111(12):1492-1498. 10.1161/01.CIR.0000159262.18512.46 15781739
48. Gabel SA Walker VR London RE Steenbergen C Korach KS Murphy E Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury J Mol Cell Cardiol 2005, 38(2):289-297. 10.1016/j.yjmcc.2004.11.013 15698835
49. Lind JM Chiu C Ingles J Yeates L Humphries SE Heather AK Semsarian C Sex hormone receptor gene variation associated with phenotype in male hypertrophic cardiomyopathy patients J Mol Cell Cardiol 2008, 45(2):217-222. 10.1016/j.yjmcc.2008.05.016 18617186
50. Mahmoodzadeh S Eder S Nordmeyer J Ehler E Huber O Martus P Weiske J Pregla R Hetzer R Regitz-Zagrosek V Estrogen receptor alpha up-regulation and redistribution in human heart failure FASEB J 2006, 20(7):926-934. 10.1096/fj.05-5148com 16675850